Task: Answer the multiple-choice question.
Query: Which compound exhibits a 1.050% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: CN(CCN1CCOCC1)Cc1nc(-c2ccc3c(c2)OCO3)no1
b: Cc1ccc(NC(=O)c2cnn(C)c2)cc1[N+](=O)[O-]
Answer: a. CN(CCN1CCOCC1)Cc1nc(-c2ccc3c(c2)OCO3)no1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN(CCN1CCOCC1)Cc1nc(-c2ccc3c(c2)OCO3)no1
CN(CCN1CCOCC1)Cc1nc(-c2ccc3c(c2)OCO3)no1
N-[[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]methyl]-N-methyl-2-morpholin-4-ylethanamine